Pathstone Holdings’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$691K Buy
21,936
+11,846
+117% +$373K ﹤0.01% 1598
2025
Q4
$297K Buy
10,090
+893
+10% +$24.8K ﹤0.01% 1976
2025
Q3
$232K Buy
+9,197
New +$224K ﹤0.01% 2139
2025
Q1
Sell
-11,299
Closed -$286K 2364
2024
Q4
$286K Sell
11,299
-3,250
-22% -$82.4K ﹤0.01% 1990
2024
Q3
$363K Buy
14,549
+407
+3% +$12.1K ﹤0.01% 1888
2024
Q2
$419K Sell
14,142
-896
-6% -$24.9K ﹤0.01% 1788
2024
Q1
$453K Buy
15,038
+7,561
+101% +$210K ﹤0.01% 1729
2023
Q4
$214K Buy
+7,477
New +$220K ﹤0.01% 2030

Other funds holding RTO

Pathstone Holdings's RTO Position: Q1 2026 in Review

Pathstone Holdings increased its Rentokil (RTO) stake by 117% in Q1 2026, buying an estimated $373K and bringing the position to 21,936 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

Pathstone Holdings first reported a position in RTO in Q4 2023 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Pathstone Holdings held 21,936 shares of Rentokil worth $691K as of Q1 2026.
  • Pathstone Holdings bought 11,846 Rentokil shares in Q1 2026, an estimated $373K.
  • Rentokil made up ﹤0.01% of Pathstone Holdings's portfolio in Q1 2026, its #1598 holding.
  • Pathstone Holdings first reported a position in Rentokil in Q4 2023 and has held it in 8 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.